Hyperbaric treatment for autism reports significant clinical improvements

Mar 13, 2009

Hyperbaric treatment for children with autism has reportedly led to improvements in the condition, though previous studies were uncontrolled. Now, a new study published in the open access journal, BMC Pediatrics, is the first controlled trial to report clinical improvements.

Hyperbaric therapy traditionally involves inhaling up to 100% oxygen at a pressure greater than 1 atmosphere (atm) in a pressurized chamber. In the first randomized, controlled, double-blind multicenter trial, Dan Rossignol and colleagues, from six centers in the USA, studied 62 , aged 2-7 years, to assess the efficacy of hyperbaric in children with .

The children were randomly assigned to either 40 hours of hyperbaric treatment at 1.3 atm and 24% oxygen (treatment group) or slightly pressurized room air at 1.03 atm and 21% oxygen (non-treatment group). Clinical outcomes were evaluated by three different scales: the Clinical Global Impression (CGI) scale, the (ABC), and the Autism Treatment Evaluation Checklist (ATEC).

The study found that children with autism in the treatment group had significant improvements in overall functioning, , , eye contact, and sensory/cognitive awareness compared to children in the non-treatment group.

Rossignol wrote "Hyperbaric treatment is a safe treatment modality at 1.3 atm and ... appears to be a promising treatment for children with autism".

More information: Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial, Daniel A Rossignol, Lanier W Rossignol, Scott Smith, Cindy Schneider, Sally Logerquist, Anju Usman, Jim , Eric M Madren, Gregg Hintz, Barry Grushkin and Elizabeth A Mumper, BMC Pediatrics (in press), http://www.biomedcentral.com/bmcpediatr/

Source: BioMed Central (news : web)

Explore further: Reporting on Ebola and how the media can learn from the past

add to favorites email to friend print save as pdf

Related Stories

Epilepsy drug may increase risk of autism in children

Dec 01, 2008

A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child's risk of developing autism. The preliminary research is published in the December 2, 2008, print issue ...

Evidence lacking to guide treatment for sudden hearing loss

Jun 18, 2007

Although steroids are the most widely used treatment for sudden hearing loss, little scientific evidence supports their use or that of any other therapies for this condition, according to a systematic review and meta-analysis ...

Study finds preemies more likely to score positive

Jan 29, 2009

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), in collaboration with other medical centers, have found that children born more than three months premature, are at three times ...

Recommended for you

Long wait yet for Ebola vaccine: experts

38 minutes ago

It will be months, at least, before a vaccine becomes available to tackle Ebola, experts said Thursday as researchers reported success in early, safety tests with a leading candidate.

Sierra Leone to miss target for beating Ebola: UN

1 hour ago

The United Nations' Ebola response mission admitted Thursday it was going to miss its target for beating the deadly epidemic in Sierra Leone due to a chronic shortage of hospital beds.

Global Ebola toll rises to 5,689: WHO

5 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

Nik_2213
not rated yet Mar 13, 2009
Now why would that be ???

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.